Gates Foundation Strategic Investment Fund Logo
>
Share this page:

Vir Biotechnology

VIR Logo

Vir Biotechnology is a newly-formed company based in San Francisco focused on finding innovative solutions to unmet needs in infectious disease. The foundation’s investment in Vir will support the development of affordable and accessible HIV and TB prophylactic vaccine programs, and support the development of a new partner in the infectious disease space.

Investment Date: December 2016

Press Release
News Story